P. D. Sloane, Dizziness: State of the Science, Annals of Internal Medicine, vol.134, p.823, 2001.

,

R. D. Adams, M. Victor, and A. H. Ropper, Principles of Neurology, pp.300-301, 1997.

K. Hanley, O. Dowd, and T. , Symptoms of vertigo in general practice: a prospective study of diagnosis, Br J Gen Pract, vol.52, pp.809-821, 2002.

T. Brandt, M. Dieterich, and M. Strupp, Vertigo and Dizziness: Common Complaints, 2013.

M. Karatas, Central Vertigo and Dizziness: Epidemiology, Differential Diagnosis, and Common Causes, The Neurologist, vol.14, p.355, 2008.

G. Royl, C. J. Ploner, M. Möckel, and C. Leithner, , 2010.

, Nervenarzt, vol.81, pp.1226-1230

P. D. Sloane, Dizziness in primary care. Results from the National Ambulatory Medical Care Survey, J Fam Pract, vol.29, pp.33-38, 1989.

C. E. Corrales and N. Bhattacharyya, Dizziness and death: An imbalance in mortality, The Laryngoscope, vol.126, pp.2134-2136, 2016.

N. Chawla and J. S. Olshaker, Diagnosis and Management of Dizziness and Vertigo, Med Clin North Am, vol.90, pp.291-304, 2006.

H. K. Neuhauser, M. Von-brevern, A. Radtke, F. Lezius, M. Feldmann et al., Epidemiology of vestibular vertigo: a neurotologic survey of the general population, Neurology, vol.65, issue.6, pp.898-904, 2005.

,

H. K. Neuhauser, Chapter 5 -The epidemiology of dizziness and vertigo, Handbook of Clinical Neurology, pp.67-82, 2016.

A. Rieger, U. Mansmann, and W. Maier, Gesundheitswesen, vol.76, pp.32-38, 2014.

K. Kroenke, C. A. Lucas, M. L. Rosenberg, B. Scherokman, J. E. Herbers et al., Causes of Persistent Dizziness: A Prospective Study of 100 Patients in Ambulatory Care, Ann Intern Med, vol.117, pp.898-904, 1992.

,

E. Neuzil, S. Ravaine, and H. Cousse, La N-acetyl-DL-leucine, médicament symptomatique des états vertigineux, Bulletin de la société de pharmacie de, vol.141, pp.15-38, 2002.

N. Vibert and P. P. Vidal, In vitro effects of acetyl-DL-leucine (Tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig, Eur J Neurosci, vol.13, p.73548, 2001.

C. Ferber-viart, C. Dubreuil, and P. P. Vidal, Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy, Audiol Neuro-otol, vol.14, p.1725, 2009.

S. Becker-bense, R. Feuerecker, and G. Xiong, Effects of acetyl-dl-leucine on the cerebral activation pattern in cerebellar ataxia (FDG-PET study), Clinical Neurophysiology, vol.126, p.115, 2015.

,

, Commission de la Transparence HAS -avis du 9 novembre 2016: Tanganil®, vol.19, 2011.

&. Medic and . Am, Données mensuelles et annuelles sur les médicaments remboursés par l'Assurance Maladie en 2017, 2018.

A. Liberati, D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gøtzsche et al., The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration, PLoS Med, vol.6, issue.7, p.1000100, 2009.

F. Chinellato, Experimental research on the behavior of vestibular function after the administration of certain drugs. II. Acetyl-DL-leucine, Boll Soc Ital Biol Sper, vol.36, p.112830, 1960.

L. Günther, R. Beck, G. Xiong, H. Potschka, K. Jahn et al., N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamus, PLoS ONE, vol.10, 2015.

F. Platt and M. Strupp, An anecdotal report by an Oxford basic neuroscientist: effects of acetyl-DL-leucine on cognitive function and mobility in the elderly, J Neurol, vol.263, p.123940, 2016.

G. Clément, O. Deguine, M. Bourg, and A. Pavy-letraon, Effects of vestibular training on motion sickness, nystagmus, and subjective vertical, J Vestib Res, vol.17, p.22737, 2007.

M. Strupp, J. Teufel, M. Habs, R. Feuerecker, C. Muth et al., Effects of acetyl-DLleucine in patients with cerebellar ataxia: a case series, J Neurol, vol.260, p.255661, 2013.

R. Schniepp, M. Strupp, M. Wuehr, K. Jahn, M. Dieterich et al., Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia-a case series, Cerebellum Ataxias, vol.3, 2016.

T. Bremova, V. Malinová, and Y. Amraoui, Acetyl-dl-leucine in Niemann-Pick type C: A case series, Neurology, vol.85, pp.1368-1375, 2015.

K. Feil, C. Adrion, and J. Teufel, Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial, BMC Neurol, vol.17, 2017.

K. Feil, T. Bremova, and C. Muth, Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus, The Cerebellum, vol.15, pp.38-42, 2016.

K. Hussain and A. G. Schilder, Betahistine for symptoms of vertigo, Cochrane Database Syst Rev, vol.21, 2016.

C. Adrion, C. S. Fischer, J. Wagner, R. Gürkov, U. Mansmann et al., Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial), BMJ, vol.352, p.6816, 2016.

M. N. Mcdonnell and S. L. Hillier, Vestibular rehabilitation for unilateral peripheral vestibular dysfunction, 2015.

, Cochrane Database Syst Rev, vol.1

M. P. Hilton and D. K. Pinder, The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo, Cochrane Database Syst Rev, vol.12, 2014.

R. Boussageon, E. Foucher, and C. Huas, Connaissances des médecins généralistes sur l'efficacité de sept médicaments courants : Enquête par questionnaire, ANSM. Notice patient Tanganil. ANSM, vol.13, pp.205-210, 2017.

P. Louhiala, H. Hemilä, and R. Puustinen, Impure placebo is a useless concept, Theor Med Bioeth, vol.36, issue.4, pp.279-89, 2015.

I. Hasham, Family Physicians Believe the Placebo Effect Is Therapeutic But Often Use Real Drugs as Placebos, Family Medicine, vol.42, pp.636-678, 2010.